The University of Southampton
University of Southampton Institutional Repository

IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation

IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation
IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation

The failure of autologous hematopoietic stem cell transplantation (HSCT) has been associated with a profound immunodeficiency that follows shortly after treatment, which renders patients susceptible to opportunistic infections and/or cancer relapse. Thus, given the additional immunosuppressive pathways involved in immune evasion in cancer, strategies that induce a faster reconstitution of key immune effector cells are needed. Natural killer (NK) cells mediate potent anti-tumor effector functions and are the first immune cells to repopulate after HSCT. TGF-β is a potent immunosuppressive cytokine that can impede both the development and function of immune cells. Here, we evaluated the use of an immunotherapeutic regimen that combines low dose of IL-2, an NK cell stimulatory signal, with TGF-β neutralization, in order to accelerate NK cell reconstitution following congenic HSCT in mice by providing stimulatory signals yet also abrogating inhibitory ones. This therapy led to a marked expansion of NK cells and accelerated NK cell maturation. Following HSCT, mature NK cells from the treated recipients displayed an activated phenotype and enhanced anti-tumor responses both in vitro and in vivo. No overt toxicities or adverse effects were observed in the treated recipients. However, these stimulatory effects on NK cell recovery were predicated upon continuous treatment as cessation of treatment led to return to baseline levels and to no improvement of overall immune recovery when assessed at later time-points, indicating strict regulatory control of the NK cell compartment. Overall, this study still demonstrates that therapies that combine positive and negative signals can be plausible strategies to accelerate NK cell reconstitution following HSCT and augment anti-tumor efficacy.

2072-6694
Alvarez, Maite
6f1c726f-6675-44de-8fd4-c81b109e3ab4
Dunai, Cordelia
28579a87-d6e5-4ba0-abd3-900e8cdfff98
Khuat, Lam T
ca00b1c8-4f0e-4f61-bb1a-493f120cef8e
Aguilar, Ethan G
556396ca-71bc-484b-87bd-8282da13d787
Barao, Isabel
38c5744b-f492-4c22-9875-5a79eb2616e6
Murphy, William J
290fec7b-1d9f-4d5d-80f3-4154fda8970c
Alvarez, Maite
6f1c726f-6675-44de-8fd4-c81b109e3ab4
Dunai, Cordelia
28579a87-d6e5-4ba0-abd3-900e8cdfff98
Khuat, Lam T
ca00b1c8-4f0e-4f61-bb1a-493f120cef8e
Aguilar, Ethan G
556396ca-71bc-484b-87bd-8282da13d787
Barao, Isabel
38c5744b-f492-4c22-9875-5a79eb2616e6
Murphy, William J
290fec7b-1d9f-4d5d-80f3-4154fda8970c

Alvarez, Maite, Dunai, Cordelia, Khuat, Lam T, Aguilar, Ethan G, Barao, Isabel and Murphy, William J (2020) IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation. Cancers, 12 (11). (doi:10.3390/cancers12113189).

Record type: Article

Abstract

The failure of autologous hematopoietic stem cell transplantation (HSCT) has been associated with a profound immunodeficiency that follows shortly after treatment, which renders patients susceptible to opportunistic infections and/or cancer relapse. Thus, given the additional immunosuppressive pathways involved in immune evasion in cancer, strategies that induce a faster reconstitution of key immune effector cells are needed. Natural killer (NK) cells mediate potent anti-tumor effector functions and are the first immune cells to repopulate after HSCT. TGF-β is a potent immunosuppressive cytokine that can impede both the development and function of immune cells. Here, we evaluated the use of an immunotherapeutic regimen that combines low dose of IL-2, an NK cell stimulatory signal, with TGF-β neutralization, in order to accelerate NK cell reconstitution following congenic HSCT in mice by providing stimulatory signals yet also abrogating inhibitory ones. This therapy led to a marked expansion of NK cells and accelerated NK cell maturation. Following HSCT, mature NK cells from the treated recipients displayed an activated phenotype and enhanced anti-tumor responses both in vitro and in vivo. No overt toxicities or adverse effects were observed in the treated recipients. However, these stimulatory effects on NK cell recovery were predicated upon continuous treatment as cessation of treatment led to return to baseline levels and to no improvement of overall immune recovery when assessed at later time-points, indicating strict regulatory control of the NK cell compartment. Overall, this study still demonstrates that therapies that combine positive and negative signals can be plausible strategies to accelerate NK cell reconstitution following HSCT and augment anti-tumor efficacy.

Text
cancers-12-03189 - Version of Record
Available under License Creative Commons Attribution.
Download (14MB)

More information

Accepted/In Press date: 27 October 2020
Published date: 29 October 2020

Identifiers

Local EPrints ID: 495584
URI: http://eprints.soton.ac.uk/id/eprint/495584
ISSN: 2072-6694
PURE UUID: ac61eeb0-4406-4079-9293-69904bed297f

Catalogue record

Date deposited: 18 Nov 2024 17:48
Last modified: 18 Nov 2024 17:49

Export record

Altmetrics

Contributors

Author: Maite Alvarez
Author: Cordelia Dunai
Author: Lam T Khuat
Author: Ethan G Aguilar
Author: Isabel Barao
Author: William J Murphy

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×